To evaluate the effectiveness and safety of piribedil for the symptomatic treatment of Parkinson's disease in monotherapy or adjuvant to levodopa.
This is a protocol.
Piribedil for symptomatic management of Parkinson's disease
You may also be interested in:
- There is not enough evidence about the safety and effectiveness of amantadine for people with dyskinesia in Parkinson's disease.
- There is not enough evidence about the safety and effectiveness of amantadine for people with Parkinson's disease.
- Beta-blockers may be able to help relive tremor for people with Parkinson's disease, but more research is needed on safety and effectiveness.
- Bromocriptine for levodopa-induced motor complications in Parkinson's disease
- Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
Health topics: